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Purpose: Retinal ischemia/reperfusion (I/R) injury plays an important role in the pathophysiology of various ocular
diseases. Retinal ganglion cells (RGCs) are particularly vulnerable to ischemia. Hydrogen sulfide (H2S) was recently
shown to be neuroprotective in the brain and retina due to its antiapoptotic effects. Rapid preconditioning of retinal neurons
by inhaled H2S before I/R injury may reduce apoptosis in the rat retina.
Methods: I/R injury was created on the left eye of rats (n=8) with or without inhaled H2S preconditioning (80 ppm) for
one hour before ischemia. Densities of fluorogold prelabeled RGCs were analyzed 7 days after injury in retinal whole
mounts. Retinal tissue was harvested to analyze protein expression of heat shock protein (HSP)-90 and the mitogen-
activated protein kinases (MAPKs) c-jun N-terminal kinase (JNK), extracellular signal-regulated kinase (ERK)1/2 and
p38 to elucidate a possible pathway of neuroprotection. DNA binding activity of the transcription factors nuclear factor-
kappa-light-chain-enhancer of activated B-cells (NF-κB), cyclic adenosine monophosphate response element binding
protein (CREB), and heat shock element (HSE), as well as caspase-3 cleavage and activity, were determined. Retinal
sections were further assessed using anti–glial fibrillary acidic protein staining.
Results: RGC death after I/R injury decreased by 41.5% after H2S preconditioning compared to room air (p<0.001).
H2S inhalation before ischemia reduced caspase-3 cleavage (p<0.001) and attenuated caspase-3 activity (p<0.001).
Furthermore, HSP-90 expression was significantly elevated in the retina after H2S preconditioning. NF-κB but not CREB
or HSE showed specific, H2S-dependent regulation, as well as the MAPKs ERK1/2 and JNK but not p38.
Conclusions: H2S preconditioning mediates antiapoptotic effects in retinal I/R injury, thus exhibiting neuroprotection.
Based on these observations, H2S could represent a novel and promising therapeutic agent to counteract neuronal injuries
in the eye. Further studies are needed to prove H2S’s neuroprotective propensity using a postconditioning approach.
Ischemia/reperfusion (I/R) injury plays an important role
in  the  pathophysiology  of  eye  diseases  such  as  diabetic
retinopathy [1], retinal vascular occlusion [2], anterior optic
neuropathy  [3],  and  possibly  glaucoma  [4,5].  It  may
ultimately lead to neuronal death by inducing apoptosis [6] or
necrosis [7]. Of the different retinal neurons, retinal ganglion
cells (RGCs) are particularly vulnerable to ischemia [8,9]. An
option to increase the organ’s resistance to such injury is the
concept of ischemic preconditioning (IPC), first introduced
by  Murry  et  al.  [10].  The  concept  implies  that  a  brief
subcritical ischemic or chemical challenge could mobilize
intrinsic  protective  mechanisms,  increasing  tolerance  to
subsequent  critical  ischemia.  This  induction  of  ischemic
tolerance has gained attention as a robust neuroprotective
mechanism.  Two  types  of  preconditioning  have  been
identified to develop the tolerant state, one that occurs very
rapidly (within 1 h) [11,12] and a second that develops slowly
(over days) [13]. In the retina, the delayed type of IPC (brief
episodes  of  ischemia  or  systemic  hypoxia)  has  been  well
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established [6,14]. We recently detected a neuroprotective
effect using rapid IPC with inhalative carbon monoxide (CO)
before ischemia in the rat retina [15].
Hydrogen  sulfide  (H2S)  is  generally  thought  to  be  a
poisonous  gas  [16].  However,  relatively  high  endogenous
levels of H2S have recently been measured in the brains of rats
and humans [17]. As H2S is produced in the brain, it may play
a role in synaptic transmission. Intensive research over the last
several years revealed its involvement in neurotransmission,
neuroprotection, and smooth muscle relaxation [18]. After
Blackstone et al. [19,20] demonstrated prolonged survival of
mice under hypoxic conditions after H2S exposure, a series of
investigations was launched to analyze the cyto- and organ-
protective effects of H2S in detail; however, these are not yet
fully understood. The physiologic effects of endogenous H2S
range  from  Ca2+-  and  calmodulin-mediated  neuronal
excitation  [21]  to  vasorelaxation  via  stimulation  of  ATP
(ATP)-sensitive potassium channels [22]. Another effect on
neurons is that H2S protects them by increasing levels of the
major  and  potent  antioxidant  glutathione  through  the
enhancement of γ-glutamylcysteine activity [23]. Especially
in myocardial I/R models, the protective effects of H2S have
been proven in combination with the beneficial function of
myocardiac  muscle  cells  via  their  antiapoptotic  and  anti-
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1275inflammatory properties [24-27]. In vitro, the neuroprotective
properties of H2S seem to partly involve the mitochondrial
function, as well as the heat shock response and a modulation
of the mitogen-activated protein kinases (MAPKs) [23,28,
29]. Thus, it appears that the effects of H2S through these
intracellular  signaling  pathways  are  orientated  toward
neuroprotection against immunological (e.g., inflammation)
and oxidative (e.g., reactive oxygen species) stress and the
promotion of survival and development [30].
Only  recently,  Osborne  et  al.  [31]  reported  a
neuroprotective effect of the H2S donor ACS67, a derivative
of  latanoprost  acid,  after  retinal  ischemia  and  after  an
oxidative insult to RGC-5 cells in culture. To date, there have
been no data concerning possible protective effects of inhaled
H2S in relation to retinal cells. We chose the rapid form of
preconditioning  to  investigate  H2S-related  mechanisms  in
apoptosis and neuronal survival in the rat retina after I/R
injury. As no specific receptor or pathway has been identified
as mediating H2S’s cytoprotective effects so far, we screened
some of the common pathways and molecules with regard to
neuroprotection. Besides the analysis of the effector caspase-3
and the transcription factors cyclic adenosine monophosphate
(cAMP)  response  element  binding  protein  (CREB)  and
nuclear  factor-kappa-light-chain-enhancer  of  activated  B-
cells  (NF-κB),  we  studied  the  modulation  of  the
phosphorylated  MAPK  c-Jun  N-terminal  kinase  (JNK),
extracellular signal-regulated kinase 1/2 (ERK1/2) and p38
kinase, as well as the heat shock response. We hypothesized
that inhalation of H2S before I/R injury may reduce apoptosis,
thus exerting neuroprotective effects. We conducted this study
in an identical way in the exact same animal model using an
identical stressful stimulus as described for CO [15] to make
a comparison of the obtained results possible, and to examine
whether these gaseous neurotransmitters exert their effects
through different molecular pathways.
METHODS
Animals: Adult male and female Sprague-Dawley rats (300–
350 g bodyweight; Charles River, Sulzfeld, Germany) were
used in this study. Animals were fed a standard rodent diet ad
libitum  while  kept  on  a  12h:12h  light-dark  cycle.  All
procedures involving the animals concurred with the ARVO
Statement for the Use of Animals in Ophthalmic and Vision
Research and were approved by the Committee of Animal
Care of the University of Freiburg. All types of surgery and
manipulations were performed under general anesthesia with
isoflurane/O2 for retrograde labeling with fluorogold (FG) or
with a mixture of intraperitoneally administered ketamine
50 mg/kg (Ceva-Sanofi, Duesseldorf, Germany) and xylazine
2  mg/kg  (Ceva-Sanofi)  for  the  ischemia  and  reperfusion
experiment.  Body  temperature  was  maintained  at  37  °C
±0.5 °C with a heating pad and a rectal thermometer probe.
After surgery, buprenorphine (Temgesic® 0.5 mg/kg; Essex
Pharma, Solingen, Germany) was applied intraperitoneally to
prevent pain. During recovery from anesthesia, the animals
were  placed  in  separate  cages,  and  gentamicin  ointment
(Refobacin;  Merck,  Darmstadt,  Germany)  was  applied  on
ocular surfaces and skin wounds. Eight animals per group
were used for RGC quantification and molecular analysis. For
proteomics and electrophoretic mobility shift assay (EMSA),
the tissue was harvested 24 h after I/R injury.
Retrograde  retinal  ganglion  cell  labeling:  Deeply
anesthetized  rats  were  placed  in  a  stereotactic  apparatus
(Stoelting, Kiel, Germany), and the skin overlying the skull
was cut open and retracted. The lambda and bregma sutures
served  as  landmarks  for  drilling  six  holes.  FG  (7.8  µl;
Fluorochrome  LLC;  Denver,  CO)  dissolved  in  dimethyl
sulfoxide (DMSO) was injected into both superior colliculi.
To ensure proper RGC labeling, animals were allowed 7 days
for retrograde transport of FG before further experimental
intervention.
Hydrogen sulfide (H2S) preconditioning and retinal ischemia/
reperfusion injury: To evaluate the neuroprotective effect of
inhalative H2S, animals were randomly assigned to receive
preconditioning with room air or room air supplemented with
80 ppm H2S (Air Liquide, Kornwestheim, Germany), both for
1 h in a sealed chamber before the experiment. During this
inhalation, rats were awake and freely moving in their cages.
They  were  anesthetized  intraperitoneally  (the  procedure
lasted  approximately  10  min)  immediately  after
preconditioning, and the anterior chamber of the left eye was
cannulated with a 30-gauge needle connected to a reservoir
containing 0.9% NaCl. Intraocular pressure was increased to
120 mmHg for 60 min, and ocular ischemia was confirmed by
interruption of the ocular circulation, as described previously
[32]. Thereafter, the cannula was immediately retracted, and
the adequacy of retinal reperfusion was confirmed visually by
an ophthalmoscope. The right eyes served as controls. Rats
that did not recover from retinal perfusion 3 min after the end
of the ischemic period and those with lens injury (which
prevents RGC death and promotes axonal regeneration [33])
were excluded from the investigation.
Retinal ganglion cell quantification: Animals were sacrificed
by CO2 inhalation 7 days after ischemia. Retinal tissue was
immediately  harvested  and  further  processed  for  whole-
mount preparation in ice-cold Hanks balanced salt solution.
Retinas were carefully placed on a nitrocellulose membrane
with the ganglion cell layer (GCL) on top. After the vitreous
body  was  removed,  retinas  were  fixed  in  4%
paraformaldehyde for 1 h and then embedded in mounting
media  (Vectashield;  AXXORA,  Loerrach,  Germany).  The
densities of FG-positive RGCs were determined in a blinded
fashion with a fluorescence microscope (AxioImager; Carl
Zeiss, Jena, Germany) and the appropriate bandpass emission
filter (FG: excitation/emission, 331/418 nm), as previously
described  [34].  Briefly,  we  photographed  three  standard
rectangular  areas  (each  measuring
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optic disc in the central region of each retinal quadrant. Hence,
we  evaluated  an  area  measuring  0.48  mm2/retina
(12×0.04 mm2), which represents approximately 1% of the rat
retina, assuming an average area per retina of approximately
50 mm2 in rats. To determine the number of cells per square
millimeter,  we  multiplied  the  number  of  analyzed  cells/
0.04 mm2 by 25. Secondary FG-stained activated microglial
cells  were  separated  by  morphological  criteria  after  RGC
phagocytosis  and  were  excluded  from  examination.  All
averaged data are presented as mean RGC density (cells/
mm2) ±standard deviation (SD).
Western blot analysis: Total retinal cell lysates were prepared
24 h after ischemia by the addition of 100 µl sodium dodecyl
sulfate  (SDS)  buffer  (250  mM  Tris  [pH  6.8],  10%  SDS,
500 mM dithiothreitol, 50% glycerol, and 0.5% bromophenol
blue).  Five  micrograms  of  total  cellular  extracts  were
separated on a 7.5% SDS polyacrylamide gel. Proteins were
transferred to a nitrocellulose membrane (Bio-Rad, Hercules,
CA), and the membranes were blocked with 5% skim milk in
Tween-20/phosphate-buffered saline and incubated with the
indicated protein-specific antibodies (pro-caspase-3 #9662,
cleaved caspase-3 #9661, p-JNK #9251, p-ERK #9101, and
p-p38 #9211; Cell Signaling, Danvers, MA) overnight at 4 °C.
After incubation with a horseradish peroxidase-conjugated
antirabbit immunoglobulin antibody, proteins were visualized
with an enhanced chemiluminescence kit (GE Healthcare,
Little Chalfont, UK). For normalization, blots were reprobed
with  a  housekeeping  antibody  or  total  form  of  MAPK
(glyceraldehyde  3-phosphate  dehydrogenase  [GAPDH]
#2118,  JNK  #9258,  ERK  #9102  and  p38  #9228;  Cell
Signaling) and were analyzed by laser scanning densitometry
(Personal Densitometer; GE Healthcare).
Fluorogenic caspase-3 activity assay: Fluorogenic caspase
activity assay was performed 24 h after ischemia using full
retinal protein extracts [35]. Results are given in arbitrary
fluorescent units (RFUs) ±SD.
Enzyme-linked immunosorbent assay: Full retinal protein was
extracted  24  h  after  ischemia,  and  enzyme-linked
immunosorbent assay (ELISA) was performed according to
the  manufacturer’s  instruction  (heat  shock  protein
[HSP]-90α,  StressXPress  SPA-835;  Biomol,  Hamburg,
Germany). Protein concentration was determined using the
Bradford assay (Bio-Rad Laboratories, Munich, Germany).
Results are given in mean±SD.
Electrophoretic mobility shift assay: EMSA was performed
24 h after ischemia with [γ-32P]-ATP-labeled NF-κB, CREB,
and HSE oligonucleotides [35] using the NF-κB consensus
sequence 5′-AGT TGA GGG GAC TTT CCC AGG-3′, the
CREB consensus sequence 5′-AGA GAT TGC CTG ACG
TCA GAG ACG TAG-3′, and the HSE consensus sequence
5′-CTA GAA GCT TCT AGA AGC TTC TAG-3′. Supershift
analysis was performed using NF-κB p50 and p65 antibodies
(Sc-114x and Sc-8008x; Santa Cruz Biotechnologies, Santa
Cruz, CA) and AP-1 c-fos antibody (Sc-253x; Santa Cruz
Biotechnologies).  Sensitivity  was  achieved  using  the
respective unlabeled oligonucleotide or AP-1 as a control.
Results are given in relative densitometric units (mean±SD).
Immunohistochemistry:  Rat  eyes  (n=2)  were  enucleated  7
days after ischemia, embedded in compound (Tissue-Tek;
Sakura-Finetek, Torrance, CA), and frozen in liquid nitrogen.
Frozen sections (10 µm) were cut through the middle third of
the  eye  and  collected  on  gelatinized  slides.
Immunohistochemistry  was  performed  according  to
standardized protocols with monoclonal antibodies against
glial fibrillary acidic protein (GFAP; dilution 1:400; Sigma),
which was then conjugated with the corresponding secondary
antibody (Cy2™, dilution 1:200; Jackson ImmunoResearch,
West Grove, PA). The nuclei of retinal cells were stained with
4’,6-diamino-2-phenylindole  dihydrochloride  hydrate
(Sigma)  added  to  the  embedding  medium  (Mowiol;
Calbiochem, San Diego, CA). Slides were examined under a
fluorescence  microscope  (Axiophot;  Carl  Zeiss,  Jena,
Germany).
Statistical analysis: Data were analyzed with a computerized
statistical  program  (SigmaStat  for  Windows  Version  3.1;
Systat Software Inc., San Jose, CA). We intended to detect a
50%  reduction  in  the  H2S-mediated  protective  effects.
Assuming  an  expected  SD  of  15%  based  on  previously
published data, an a priori power analysis (a=0.05 with the
two-sided hypothesis, b=0.1, power 90%) indicated that a
sample size of seven animals per group would be sufficient to
detect such a reduction. The results are presented as means
(±SD) after normal distribution of data had been verified.
One-way ANOVA for repeated measurements was used for
between-group comparisons with the post hoc Tukey–Kramer
test.  A  p<0.05  was  considered  statistically  significant.
Autoradiographies of EMSA and western blot analysis were
evaluated by volume quantification and the local median of
protein expression, and normalization against background or
loading control using two-dimensional scanning (Personal
Densitometer; GE Healthcare, Freiburg, Germany).
RESULTS
All animals survived the experiments and were included in the
data analysis. No sign of disease or harm was recognized in
any of them. The untreated right eye in every animal served
as a control for each experiment.
H2S  preconditioning  attenuated  retinal  ganglion  cell
death after ischemia/reperfusion injury: RGC densities were
counted to analyze the effect of H2S in the context of ischemia
and reperfusion. As in control retinas exposed to room air, all
RGCs stained FG-positive in the H2S control group 7 days
after I/R injury on the opposite eye (2,573±261 or 2,602±258
RGC/mm2, respectively), data not shown. I/R injury with or
without  H2S  preconditioning  reduced  RGC  densities  to
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injury after room air inhalation led to a ~40% reduction of
viable  RGCs  (1,016±221  dead  RGC/mm2)  compared  to
untreated control eyes (p<0.001; Figure 1A). Preconditioning
with inhalative H2S attenuated RGC death after I/R injury
(only ~23% reduction of viable RGCs, 594±178 dead RGC/
mm2) compared to H2S-exposed controls (p<0.001; Figure
1A).  In  summary,  7  days  after  I/R  injury,  RGC  death
decreased by 41.5% due to H2S preconditioning compared to
room air (p<0.001). In I/R treated eyes, many RGCs died and
activated microglia cells (denoted with arrows) stained FG-
positive after RGC phagocytosis (Figure 1B).
H2S reduced apoptosis in retinal tissue after ischemia/
reperfusion  injury:  While  investigating  the  effects  of  I/R
injury and H2S on retinal apoptosis, we analyzed the cleavage
of caspase-3 and the caspase-3 activity in the retina 24 h after
ischemia. Compared to control, I/R injury led to a significant
cleavage from pro-caspase-3 to caspase-3 (Figure 2A, lane 1
versus 2). H2S preconditioning in control animals had no
significant effect (Figure 2A, lane 3). H2S preconditioning
before  I/R  injury  significantly  reduced  cleavage  of  pro-
Figure 1. Attenuated retinal ganglion cell death after hydrogen sulfide preconditioning. A: Retinal ganglion cell (RGC) loss (RGC/mm2)
presented  as  mean  difference  to  individual  control.  Data  are  presented  as  mean±SD  of  eight  experiments.  Hydrogen  sulfide  (H2S)
preconditioning decreased RGC death by 41.5% compared to room air seven days after ischemia/reperfusion (I/R) injury (***p<0.001). B:
RGC densities were not significantly different in controls exposed to room air or H2S. Fluorogold (FG)-positive RGCs can be identified by
morphological criteria (large round cell body, no processes, almost homogeneously labeled). In I/R treated eyes, many RGCs died and activated
microglia cells (small cellular body, branching processes, inhomogeneously labeled; denoted with arrows in the extracts) stained FG-positive
after RGC phagocytosis. H2S preconditioning partly antagonized this effect, leading to significantly higher cell densities. The scale bar
represents 100 µm.
Molecular Vision 2011; 17:1275-1286 <http://www.molvis.org/molvis/v17/a143> © 2011 Molecular Vision
1278caspase-3 to caspase 3 (Figure 2A, lane 4 versus 2; p<0.001).
In agreement with this data, caspase-3 activity was low in
control eyes and was not affected by H2S inhalation in the
control  eyes  of  H2S-preconditioned  animals  (Figure  2B,
99±34 versus 180±73 RFU). I/R injury increased the activity
to 750±154 RFU (p<0.001 compared with control eyes). In
contrast, preconditioning with inhaled H2S reduced caspase-3
activity significantly (Figure 2B, 320±117 versus 750±154
RFU; p<0.001).
H2S attenuated glial fibrillary acidic protein expression
in the retina after ischemia/reperfusion injury: Histological
analysis of the retina was performed 7 days after unilateral I/
R injury. In controls with and without H2S preconditioning,
GFAP was only positive in Müller cells and astrocytes in the
GCL (Figure 3A). After ischemia, GFAP was upregulated in
Müller cells. Their processes, extending through all retinal
layers, became strongly GFAP-positive. This upregulation
seemed to be stronger in the I/R injury plus room air group,
thus correlating with the degree of retinal damage.
H2S increased HSP-90α expression in retinal tissue: In
nonpreconditioned  eyes  (control  and  I/R  injury),  retinal
HSP-90α expression remained at baseline levels (Figure 3B,
0.6±0.2 and 0.5±0.3 ng/ml, respectively) 24 h after unilateral
ischemia.  H2S  preconditioning  significantly  increased
Figure 2. Hydrogen sulfide preconditioning–mediated antiapoptotic effects. A: Effect of hydrogen sulfide (H2S) preconditioning on caspase-3
activation 24 h after unilateral ischemia. Pro-caspase-3 and caspase-3 levels were determined using specific antibodies. Histograms represent
the densitometric ratio of caspase-3 cleavage compared with loading control (glyceraldehyde 3-phosphate dehydrogenase [GAPDH]). The
amount of pro-caspase-3 and protein loading seemed comparable in all groups (lanes 1–4). Compared to control, ischemia/reperfusion (I/R)
injury led to a significant cleavage from pro-caspase-3 to active caspase-3 (lane 1 versus 2). H2S preconditioning before I/R injury significantly
reduced cleavage of pro-caspase-3 to caspase 3 (lane 4 versus 2; ***p<0.001). Data are presented as mean±SD of five experiments. B:
Fluorogenic caspase-3 assay (DEVDase assay) of full retinal protein lysates 24 h after I/R injury. Caspase-3 activity was low in control eyes
(room air) and was not significantly affected by H2S inhalation in controls. I/R injury increased the activity (p<0.001 compared with control
eye). In contrast, preconditioning with inhaled H2S significantly reduced caspase-3 activity in ischemic tissue. Results are given in RFUs.
Data are presented as mean±SD of eight experiments. ***p<0.001 I/R injury versus H2S + I/R injury.
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versus control) and ischemic eyes (Figure 3B, 2.5±0.6 versus
0.5±0.3 ng/ml, p<0.001); thus, this upregulation seems to be
independent of I/R injury.
H2S  reduced  DNA-binding  activity  of  NF-κB  after
ischemia:  EMSA  was  performed  24  h  after  ischemia  to
analyze the binding activity of transcription factors. Control
and I/R injured eyes with and without H2S preconditioning did
not reveal any DNA binding of CREB or HSE (data not
shown). Compared to control, I/R injury increased the DNA
binding of NF-κB significantly (Figure 4, lane 1 versus 2;
sixfold  induction  versus  control,  p<0.001).  While  H2S
preconditioning without injury did not alter DNA binding,
H2S  inhalation  before  I/R  injury  counteracted  the  DNA
binding of NF-κB completely (Figure 4, lane 4 versus 2, 5.8
fold reduction versus I/R injury, p<0.001). Specific supershift
analysis revealed that p50 is the main part of the transactive
NF-κB  domain  (Figure  4,  lane  6),  while  the  unspecific
antibody  (c-fos  [AP-1])  did  not  lead  to  a  supershift.  The
oligo’s  sensitivity  was  demonstrated  by  competition
experiments with unlabeled NF-κB (Figure 4, lane 7) and
unlabeled AP-1 (Figure 4, lane 8).
H2S  mediated  differential  mitogen  activated  protein
kinase  regulation  in  the  retina:  The  MAPK  ERK1/2  is
suppressed through inhalational H2S preconditioning. While
p-ERK was baseline activated in the nonpretreated animals
(control and I/R injury), H2S significantly inhibited ERK1/2
phosphorylation in both control and ischemic retinas (Figure
5A, fourfold reduction in H2S + I/R injury versus I/R injury;
p<0.05). In contrast, I/R injury per se significantly increased
the phosphorylation of JNK (Figure 5B, 3.8 fold induction in
I/R injury versus control; p<0.001). Again, preconditioning
with  inhalative  H2S  inhibited  JNK  phosphorylation
completely (Figure 5B, 3.7 fold reduction in H2S+I/R injury
versus  I/R  injury;  p<0.001).  The  phosphorylation  of  p38
MAPK  was  comparable  in  all  groups  without  significant
differences (Figure 5C).
DISCUSSION
The main findings of this experimental in vivo study can be
summarized  as  follows:  Ischemia  and  reperfusion  cause
significant neuronal injury in the retina, characterized by a
reduced number of viable RGCs; inhalation of H2S before
ischemia reduces RGC loss and attenuates caspase-3 cleavage
as well as caspase-3 activity, thus acting antiapoptotically;
H2S preconditioning further reduces GFAP activation in the
retina  and  increases  the  protein  expression  of  HSP-90α;
possible  mechanisms  of  the  H2S-mediated  protection  are
suppression of the transcription factor NF-κB and differential
expression of MAPKs. These findings support our hypothesis
that  rapid  preconditioning  with  inhaled  H2S  mediates
antiapoptotic and thus neuroprotective effects in the rat retina
after I/R injury.
The molecular mechanisms of rapid preconditioning are
not  fully  understood;  however,  posttranslational
modifications  seem  to  play  a  key  role  in  mediating
neuroprotection  in  that  form.  In  many  models  of  delayed
preconditioning, new protein synthesis is required, suggesting
Figure 3. Hydrogen sulfide–attenuated glial fibrillary acidic protein expression and increased heat shock protein (HSP)-90 expression in retinal
tissue. Effect of hydrogen sulfide (H2S) preconditioning on retinal glial fibrillary acidic protein (GFAP; A) and HSP-90 (B) expression. A:
Cross-sections of the retinas 7 days after unilateral ischemia/reperfusion (I/R) injury. In controls with and without H2S preconditioning, GFAP
was only positive in Müller cells and astrocytes in the ganglion cell layer (GCL). After ischemia, GFAP was upregulated in Müller cells. Their
processes, extending through all retinal layers, became strongly GFAP positive. This upregulation seemed to be stronger in the I/R injury +
room air group. The scale bar represents 50 µm. B: In nonpreconditioned eyes (control and ischemic), retinal HSP-90 expression remained at
the baseline level. H2S preconditioning in control eyes significantly increased HSP-90 expression. H2S inhalation before I/R injury significantly
induced retinal HSP-90 expression compared with I/R injury alone (***p<0.001). Data are presented as mean±SD of eight experiments.
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form  of  preconditioning.  However,  it  is  clear  that  some
changes in gene expression occur extremely rapidly, so there
may be considerable overlap in the mechanisms of rapid and
delayed preconditioning [36]. Rapid preconditioning has been
previously  observed  in  the  central  nervous  system  (CNS)
[12,37], and was recently demonstrated by our laboratory in
the rat retina for CO [15]. In some cases, neuroprotection after
rapid IPC was not as robust or long lasting as that after delayed
IPC  [12].  To  date,  there  are  no  data  concerning  possible
protective effects of inhaled H2S preconditioning on retinal
cells. In the present study, unilateral I/R injury resulted in a
loss  of  ~40%  of  viable  RGCs  in  the  retina  compared  to
uninjured controls. H2S preconditioning for 1 h before I/R
injury reduced RGC loss by 41.5% on day 7 after ischemia
compared with the I/R injury + room air group (Figure 1). This
is a significant delay of cell death one week after I/R injury.
However,  the  long-term  effect  of  H2S  preconditioning  on
RGC survival was not determined in this study. To suggest
general neuroprotection in the retina, future studies should
also  address  the  survival  promoting  effect  of  H2S
preconditioning on other retinal cells.
Previous  studies  in  rat  in  vivo  models—mainly  in
myocardial ischemia and reperfusion settings—have shown
that H2S is able to modulate and prevent cell death [24,25].
Moreover,  Tay  et  al.  reported  that  H2S—as  a  chemical
substrate derived from NaHS as a donor—protected neuronal
cells from hypoxic damage by a KATP/PKC/ERK and HSP-90
pathway [29]. Just recently, Osborne et al. first reported a
neuroprotective  action  of  the  H2S  donor  ACS67  when
administered intravitreally after retinal ischemia [31]. The
present  work  revealed  that  inhaled  H2S  before  I/R  injury
triggers  neuronal  protection  by  an  antiapoptotic  response.
Caspase-3 is the effector caspase, connecting the cellular and
mitochondrial apoptotic pathway. As described by Osipov et
al., H2S is able to reduce caspase-3 cleavage, and subsequently
caspase activity in a model of myocardial I/R injury [38].
Moreover, Osborne et al. found a reduction of apoptosis after
an oxidative insult to RGC-5 cells in culture, following the
activation  of  ACS67  [31].  In  the  same  study,  intravitreal
ACS67 administration directly after ischemia counteracted
retinal I/R injury, although the upregulation of caspase-3 and
−8 mRNA levels were not diminished by ACS67 [31]. Our
data revealed that H2S is able to attenuate caspase-3 cleavage
and caspase-3 activity (Figure 2A,B). In accordance with this,
the activation of Müller cells was reduced in retinal sections
after H2S + I/R injury (Figure 3A).
NF-κB is a transcription factor known to mediate the
stimulus-dependent  induction  of  genes  critical  to  the
inflammation and survival of neurons. Activation of NF-κB
Figure 4. Hydrogen sulfide counteracted ischemia/reperfusion-induced DNA-binding activity of nuclear factor-kappaB . Effect of hydrogen
sulfide (H2S) on the DNA-binding activity of nuclear factor-kappaB (NF-κB) in retinal tissue 24 h after unilateral ischemia. Control eyes with
and without H2S preconditioning did not reveal any DNA binding of NF-κB (lanes 1, 3). Compared to control, ischemia/reperfusion (I/R)
injury increased the DNA binding of NF-κB significantly (lane 1 versus 2; sixfold induction versus control, p<0.001). H2S inhalation before
I/R injury counteracted the ischemia-induced DNA binding of NF-κB completely (lane 4 versus 2, 5.8-fold reduction versus I/R injury,
***p<0.001). Specific supershift analysis revealed that p50 is the main part of the transactive NF-κB domain (lane 6), while the unspecific
antibody (c-fos [AP-1]) did not lead to a supershift. The oligo’s sensitivity was demonstrated by competition experiments with unlabeled NF-
κB (lane 7) and unlabeled AP-1 (lane 8). The histogram represents the densitometric ratio of NF-κB compared with the control group. Data
are presented as mean±SD of five experiments.
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1281appears  to  play  an  important  role  in  retinal  degeneration
following retinal ischemia and reperfusion injury [39,40]. It
has been demonstrated frequently that the inhibition of NF-
κB  activation  protects  retinal  neurons  in  various  animal
Figure 5. Hydrogen sulfide–induced differential mitogen-activated protein kinase regulation in the retina. Effect of hydrogen sulfide (H2S)
preconditioning on mitogen-activated protein kinases (MAPKs) phosphorylated (p)- extracellular signal-regulated kinase (ERK)1/2 (A), p-
c-jun N-terminal kinase (JNK; B), and p-p38 (C) 24 h after unilateral ischemia. MAPK levels were determined using specific antibodies. The
histograms represent the densitometric ratio of MAPKs compared with its nonphosphorylated form, total (t)ERK1/2, JNK, or p38. A: p-
ERK1/2 is suppressed through inhalational H2S preconditioning. While p-ERK was baseline activated in the nonpretreated animals (control
and ischemia/reperfusion [I/R] injury), H2S significantly inhibited ERK1/2 phosphorylation in both control and ischemic retinas (fourfold
reduction in H2S + I/R injury versus I/R injury; *p<0.05). B: I/R injury per se significantly increased the phosphorylation of the JNK (3.8-
fold induction in I/R injury versus control; p<0.001). Again, preconditioning with inhalative H2S inhibited JNK phosphorylation completely
(3.7-fold reduction in H2S + I/R injury versus I/R injury; ***p<0.001). C: The phosphorylation of p38 MAPK was comparable in all groups
without significant differences. Data are presented as mean±SD of eight experiments.
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1282models, e.g., ischemia [40], retinal degeneration [41], and
glaucoma [42]. In the present work, I/R injury significantly
induced  the  DNA  binding  of  NF-κB,  whereas  H2S
preconditioning  before  ischemia  resulted  in  the  abolished
DNA binding of NF-κB, as shown via EMSA (Figure 4).
Although there are fewer data concerning H2S involvement in
the  activation  or  suppression  of  NF-κB  [43,44],  our  data
strongly suggest that the H2S-mediated inhibition of NF-κB
activation is one component of its neuroprotective action after
retinal ischemia. It has been further demonstrated that the
inhibition of MAPK may alter NF-κB activation, thus exerting
neuroprotective effects [45,46].
CREB is a transcription factor known to mediate the
stimulus-dependent expression of genes critical to neuronal
survival. Recent studies indicate that CREB may be a key
element in the acquisition of ischemic tolerance in the brain
[47],  and  that  IPC  induces  CREB  activation  and  Bcl-2
expression in a neonatal ischemia model [48]. After retinal
injury,  CREB  decreased  in  RGCs  [49].  In  our  previous
experiments  using  CO  inhalation  for  IPC  before  retinal
ischemia, we detected a more than threefold increase of CREB
compared to controls [15]. In contrast, we were unable to
detect increased DNA-binding activity of CREB in the present
experiments.  This  is  a  clear  hint  that  H2S  mediates  its
protective  properties  at  least  in  part  through  a  different
pathway than CO.
We have chosen the MAPKs p38, pERK1/2, and pJNK
as targets worth analyzing, because the MAPKs are important
in every cellular regulation, especially cellular protection.
Furthermore,  the  MAPKs  seem  to  play  a  crucial  role  in
neuronal apoptosis; however, the data on the H2S-mediated
phosphorylation  of  MAPKs  are  discordant.  This  study
revealed  that  the  phosphorylation  and  activation  of  the
MAPKs  JNK  and  ERK1/2  but  not  p38  show  differential
expression patterns after H2S preconditioning (Figure 5A-C).
In the context of neuroprotection, the role of p38 regulation is
controversial.  An  H2S-mediated  antineuroinflammatory
effect due to p38 inhibition was previously reported by Hu et
al. [50]. In contrast, Dreixler et al. [51] reported a necessity
for  p38  activation  in  the  context  of  retinal  ischemia,  and
previous studies conducted by our laboratory demonstrated a
phosphorylation of p38 by CO preconditioning before I/R
injury [15]. Currently, there are fewer data about the effect of
H2S on ERK1/2 in brain cells. Tay et al. [29] investigated
H2S-related effects on hypoxia in neurons and concluded that
ERK1/2 is needed for neuroprotection. In contrast, we found
an H2S-induced inhibition of p-ERK1/2 in the ischemic retina.
In other types of cells, H2S was found to stimulate ERK1/2 to
induce apoptosis in human aorta smooth muscle cells [52],
cardioprotection  in  the  rat  heart  [53],  and  synthesis  of
proinflammatory cytokines in human monocytes [44]. In our
model of retinal ischemia, H2S-mediated neuroprotection was
associated  with  strongly  diminished  p-JNK  activation.
Likewise,  Shi  et  al.  found  a  rapid,  time-dependent
phosphorylation of JNK in cardial I/R injury and reported its
significant inhibition after treatment with NaHS, an H2S donor
[54]. Certainly, more experiments need to be done to clarify
this pathway. In summary, the MAPKs are also regulated in
a different way using H2S preconditioning compared to CO
preconditioning in the same injury model. While p38 is not
involved  in  H2S-mediated  protection,  JNK  and  ERK  are
expressed differentially.
HSPs  are  chaperone  molecules  that  confer  protein
stability and help to restore protein native folding following
heat shock and other stress. The most abundant HSP, HSP-90,
is also involved in regulating the stability and function of
several cell-signaling molecules. Following previous reports,
HSPs  are  crucial  for  neuronal  and  nonneuronal  survival,
especially  in  ischemia  [29,55]  and  in  the  mechanism  of
preconditioning  [56].  It  has  been  described  that  H2S
contributes cellular protection via an induction of the heat
shock response. In a model of neuronal hypoxia, HSP-90 was
induced via H2S, revealing protective properties [29]. Our data
confirmed this effect, showing a significant induction of the
cytoprotective chaperone molecule HSP-90 by the application
of H2S alone and in the context of I/R injury (Figure 3B).
Interestingly,  we  were  unable  to  detect  increased  DNA-
binding activity of HSE in the present experiments, although
the HSE and corresponding heat shock factor–1 are necessary
elements involved in the heat shock response. However, the
posttranslational  protein  modification  represents  another
option to increase HSP-90 expression; this was not further
investigated in the present study.
Despite various molecular mechanisms that have been
described  for  H2S  so  far,  no  specific  receptor  has  been
identified.  Current  evidence  suggests  that  under  certain
physiologic conditions and after neuronal injury, H2S plays a
role in promoting cell survival by its neuroprotective effects
on both neurons and glia in the CNS [30]. Current targets for
H2S  in  the  CNS  include  N-Methyl-D-aspartate  (NMDA)
receptors, as well as ATP-sensitive potassium and calcium
channels, thereby promoting changes in neuronal and glial
signaling, oxidative stress, and vascular regulation [18,57]. In
contrast, H2S appears to cause or contribute to tissue damage
[58],  depending  on  concentration,  cell  type,  and  tissue
specificity. The potential pathophysiological effects of H2S on
other  retinal  cells  such  as  photoreceptors  need  to  be
considered when using H2S. In the present study, we used
room air supplemented with 80 ppm H2S for preconditioning,
as in previous studies [20]. This dose was well tolerated by
the rats.
Regarding  the  data  presented  here,  it  is  tempting  to
propose a pathway for H2S-mediated antiapoptotic effects in
the rat retina: The exogenous, inhalative application of H2S
inhibits  caspase-3  cleavage  and  caspase-3  activity.  Our
histological  findings  strengthen  these  results,  giving
morphological evidence of RGC survival, but also of reduced
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1283glial activation. Moreover, HSP-90 expression is increased
due to H2S exposure. In part, these effects may be mediated
by the inhibition of NF-κB activation and by a differential
phosphorylation of the MAPKs ERK1/2 and JNK but not p38.
Thus, H2S seems to mediate its effects via partly different
pathways in comparison to CO. Depending on the gaseous
molecule  used,  the  mechanisms  of  protective  organic
preconditioning  are  different  in  molecular  targets,
mechanisms, and sites of action.
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